A
ISSUER//CIK 0000704292
AQUILA BIOPHARMACEUTICALS INC
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Recent Filings
- SC 13G/A20.9 KBAQUILA BIOPHARMACEUTICALS INCJan 23, 7:00 PM ET·0000891836-01-000021
- SC 13G/A8.4 KBAQUILA BIOPHARMACEUTICALS INCDec 6, 7:00 PM ET·0000950128-00-001399
- 10-Q32.7 KBAQUILA BIOPHARMACEUTICALS INCNov 12, 7:00 PM ET·0000942794-00-000047
- 8-K11.4 KBAQUILA BIOPHARMACEUTICALS INCAug 21, 8:00 PM ET·0000942794-00-000038
- 10-Q32.1 KBAQUILA BIOPHARMACEUTICALS INCAug 10, 8:00 PM ET·0000942794-00-000033
- 8-K3.8 KBAQUILA BIOPHARMACEUTICALS INCJul 13, 8:00 PM ET·0000942794-00-000031
- SC 13G/A21.0 KBAQUILA BIOPHARMACEUTICALS INCMay 18, 8:00 PM ET·0000912057-00-025528
- 8-K6.9 KBAQUILA BIOPHARMACEUTICALS INCMay 2, 8:00 PM ET·0000942794-00-000019
- 10-Q26.8 KBAQUILA BIOPHARMACEUTICALS INCApr 23, 8:00 PM ET·0000942794-00-000014
- SC 13G/A8.4 KBAQUILA BIOPHARMACEUTICALS INCApr 5, 8:00 PM ET·0000950128-00-000639
Insiders
1Tickers
No tickers on record
Addresses
business
175 CROSSING BLVD BIOTECHNOLOGY RESEARCH PARK
FRAMINGHAM, MA, 01702
mailing
175 CROSSING BOULEVARD
FRAMINGHAM, MA, 01702
Former Names
- CAMBRIDGE BIOTECH CORP1996-02-01